← Every company
Ultragenyx Pharmaceutical Inc Planned Sales
Before an insider at Ultragenyx Pharmaceutical Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
RARE insider trades →Notices on file
1
Insiders
1
Shares noticed
1.3K
permission to sell, not sales
Estimated value
$17.5K
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Huizenga TheodoreOfficer2026-09-151.3K sh<0.01% | $17.5K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on RARE
Company overviewEverything on RARE in one place, with the price.SEC filingsWhat RARE's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat RARE's own officers and directors buy and sell.Who owns itEvery manager reporting a position in RARE.Funds holding itWhich funds and ETFs hold RARE, and how big a bet.LobbyingWhat RARE spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on RARE's account, and who they worked for.PatentsWhat RARE is filing at the patent office.